Genscript Biotech Corporation (GNNSF)
OTCMKTS · Delayed Price · Currency is USD
2.070
+0.400 (23.95%)
Jul 18, 2025, 4:00 PM EDT
Genscript Biotech Market Cap
Genscript Biotech has a market cap or net worth of $4.56 billion as of July 21, 2025. Its market cap has increased by 91.57% in one year.
Market Cap
4.56B
Enterprise Value
4.67B
Revenue
594.49M
Ranking
n/a
PE Ratio
1.54
Stock Price
$2.07
Market Cap Chart
Since December 30, 2015, Genscript Biotech's market cap has increased from 272.50M to 4.56B, an increase of 1,574.36%. That is a compound annual growth rate of 34.26%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.61B |
| Veradigm | 832.17M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 599.09M |
| Glass House Brands | 434.24M |
| CytoDyn | 394.89M |
| Northwest Biotherapeutics | 386.15M |